Vaxcyte Inc. Made Big Gain

Tue, Sep 03, 2024 at 07:22 PM

Vaxcyte Inc. (PCVX:NASDAQ) soared at $110.15, representing a gain of 36.4%. On Tue, Sep 03, 2024, PCVX:NASDAQ touched a New 2-Week High of $110.15. The stock got featured on our News Catalysts scanner on Tue, Sep 03, 2024 at 06:32 PM in the 'PUBLIC OFFERING' category. From Tue, Aug 20, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days

About Vaxcyte Inc. (PCVX:NASDAQ)

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises.

Top 10 Gainers:

ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
Unico American Corporation (UNAM:NASDAQ), 155.5%
SRAX, Inc. (SRAX:NASDAQ), 133.33%
Sify Technologies Limited (SIFY:NASDAQ), 99.61%
Conifer Holdings, Inc. (CNFR:NASDAQ), 74.24%
BranchOut Food Inc. (BOF:NASDAQ), 69%
SPAR Group, Inc. (SGRP:NASDAQ), 65.52%
Asset Entities Inc. (ASST:NASDAQ), 44.37%
Sable Offshore Corp Com (SOC:NYSE), 39.13%
Vaxcyte Inc. (PCVX:NASDAQ), 36.39%